France Aesthetic Injectable Market Size & Outlook
France aesthetic injectable market, 2018-2030 (US$M)
Related Markets
France aesthetic injectable market highlights
- The France aesthetic injectable market generated a revenue of USD 472.9 million in 2023 and is expected to reach USD 991.5 million by 2030.
- The France market is expected to grow at a CAGR of 11.2% from 2024 to 2030.
- In terms of segment, botulinum toxin was the largest revenue generating product in 2023.
- Hyaluronic Acid is the most lucrative product segment registering the fastest growth during the forecast period.
Aesthetic injectable market data book summary
| Market revenue in 2023 | USD 472.9 million |
| Market revenue in 2030 | USD 991.5 million |
| Growth rate | 11.2% (CAGR from 2023 to 2030) |
| Largest segment | Botulinum toxin |
| Fastest growing segment | Hyaluronic Acid |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hyaluronic Acid, Botulinum Toxin, Aquatic Light Injections |
| Key market players worldwide | Ipsen SA, AbbVie Inc, Merz Pharma, Galderma Group AG Registered Shares, Prollenium Medical Technologies, Suneva Medical, Sinclair Pharma plc, Medytox, Revance Therapeutics Inc |
Other key industry trends
- In terms of revenue, France accounted for 4.3% of the global aesthetic injectable market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany aesthetic injectable market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 991.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Aesthetic Injectable Market Scope
Aesthetic Injectable Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France aesthetic injectable market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aesthetic injectable market will help companies and investors design strategic landscapes.
Botulinum toxin was the largest segment with a revenue share of 45.59% in 2023. Horizon Databook has segmented the France aesthetic injectable market based on hyaluronic acid, botulinum toxin, aquatic light injections covering the revenue growth of each sub-segment from 2018 to 2030.
Increased awareness among customers about the potential benefits of aesthetic procedures, coupled with the growing adoption of minimally invasive procedures, is boosting the aesthetic injectable market in France.
Furthermore, rising purchasing power, growing involvement of international players, increasing spending on cosmetics and personal care, and rising number of beauty clinics are likely to fuel the market in France.
HA injectable products, such as Perfectha by Sinclair, are popular in the country and are designed for wrinkle correction and volume restoration. Sinclair manufactures nearly 30,000 syringes of the Perfectha line each week from its unit in Lyon, France.
Reasons to subscribe to France aesthetic injectable market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France aesthetic injectable market databook
-
Our clientele includes a mix of aesthetic injectable market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France aesthetic injectable market, including forecasts for subscribers. This country databook contains high-level insights into France aesthetic injectable market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France aesthetic injectable market size, by product, 2018-2030 (US$M)
France Aesthetic Injectable Market Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
